Andrew Peng Yu

Summary

Affiliation: Analysis Group
Country: USA

Publications

  1. ncbi request reprint Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population
    Andrew P Yu
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 25:755-64. 2009
  2. doi request reprint Cost utility of adalimumab versus infliximab maintenance therapies in the United States for moderately to severely active Crohn's disease
    Andrew P Yu
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Pharmacoeconomics 27:609-21. 2009
  3. ncbi request reprint The costs of Crohn's disease in the United States and other Western countries: a systematic review
    Andrew Peng Yu
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 24:319-28. 2008
  4. doi request reprint Resource utilization and costs of schizophrenia patients treated with olanzapine versus quetiapine in a Medicaid population
    Andrew P Yu
    Analysis Group, Inc, Boston, MA, USA
    Value Health 12:708-15. 2009
  5. doi request reprint Economic burden of psoriasis compared to the general population and stratified by disease severity
    Andrew P Yu
    Analysis Group, Inc, 111 Huntington Avenue, 10th Floor, Boston, MA 02199, USA
    Curr Med Res Opin 25:2429-38. 2009
  6. doi request reprint Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study
    Andrew P Yu
    Analysis Group, Inc, Boston, MA 02199, USA
    J Med Econ 13:599-609. 2010
  7. doi request reprint Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD
    Andrew P Yu
    Analysis Group Inc, 111 Huntington Avenue, Boston, MA 02199, USA
    Respir Med 105:1861-71. 2011
  8. doi request reprint Loss of treatment response to infliximab maintenance therapy in Crohn's disease: a payor perspective
    Eric Qiong Wu
    Analysis Group, Inc, Boston, MA, USA
    Value Health 11:820-9. 2008

Detail Information

Publications8

  1. ncbi request reprint Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population
    Andrew P Yu
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 25:755-64. 2009
    ..Compare treatment patterns for patients with schizophrenia treated with olanzapine versus quetiapine in the Pennsylvania Medicaid population...
  2. doi request reprint Cost utility of adalimumab versus infliximab maintenance therapies in the United States for moderately to severely active Crohn's disease
    Andrew P Yu
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Pharmacoeconomics 27:609-21. 2009
    ..To determine and compare the cost utilities of the tumour necrosis factor (TNF) antagonists adalimumab and infliximab as maintenance therapies for patients in the US with moderately to severely active Crohn's disease...
  3. ncbi request reprint The costs of Crohn's disease in the United States and other Western countries: a systematic review
    Andrew Peng Yu
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 24:319-28. 2008
    ..To conduct a critical and systematic literature review of the costs of Crohn's disease (CD) in Western industrialized countries...
  4. doi request reprint Resource utilization and costs of schizophrenia patients treated with olanzapine versus quetiapine in a Medicaid population
    Andrew P Yu
    Analysis Group, Inc, Boston, MA, USA
    Value Health 12:708-15. 2009
    ..Compare annual health-care costs and resource utilization associated with olanzapine versus quetiapine for treating schizophrenia in a Medicaid population...
  5. doi request reprint Economic burden of psoriasis compared to the general population and stratified by disease severity
    Andrew P Yu
    Analysis Group, Inc, 111 Huntington Avenue, 10th Floor, Boston, MA 02199, USA
    Curr Med Res Opin 25:2429-38. 2009
    ..To evaluate health care utilization and costs for patients with psoriasis vs. the general population and by psoriasis severity...
  6. doi request reprint Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study
    Andrew P Yu
    Analysis Group, Inc, Boston, MA 02199, USA
    J Med Econ 13:599-609. 2010
    ....
  7. doi request reprint Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD
    Andrew P Yu
    Analysis Group Inc, 111 Huntington Avenue, Boston, MA 02199, USA
    Respir Med 105:1861-71. 2011
    ..To compare healthcare resource utilization and healthcare costs between COPD patients who used multiple long-acting inhalers versus those who used a single long-acting inhaler...
  8. doi request reprint Loss of treatment response to infliximab maintenance therapy in Crohn's disease: a payor perspective
    Eric Qiong Wu
    Analysis Group, Inc, Boston, MA, USA
    Value Health 11:820-9. 2008
    ..To assess the incidence and economic implications of loss of treatment response among patients with Crohn's disease (CD) treated with infliximab maintenance therapy...